ECM
RCUS icon

ExodusPoint Capital Management’s Arcus Biosciences RCUS Stock Holding History

ExodusPoint Capital Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-60,193
Closed -$896K – 1912
2024
Q4 		$896K Buy
+60,193
New +$983K 0.01% 978
2024
Q3 		– Sell
-58,951
Closed -$898K – 2016
2024
Q2 		$898K Buy
+58,951
New +$951K 0.01% 1057
2024
Q1 		– Sell
-182,865
Closed -$3.49M – 1884
2023
Q4 		$3.49M Sell
182,865
-70,275
-28% -$1.12M 0.02% 426
2023
Q3 		$4.54M Sell
253,140
-183,330
-42% -$3.68M 0.04% 396
2023
Q2 		$8.87M Buy
436,470
+9,258
+2% +$176K 0.07% 277
2023
Q1 		$7.79M Buy
427,212
+393,201
+1,156% +$7.52M 0.06% 364
2022
Q4 		$703K Buy
34,011
+11,116
+49% +$306K 0.01% 1066
2022
Q3 		$599K Sell
22,895
-46,492
-67% -$1.23M 0.01% 1299
2022
Q2 		$1.76M Buy
69,387
+39,600
+133% +$970K 0.02% 840
2022
Q1 		$940K Buy
+29,787
New +$998K 0.01% 1198
2021
Q1 		– Sell
-8,390
Closed -$218K – 2516
2020
Q4 		$218K Buy
+8,390
New +$203K ﹤0.01% 1690
2020
Q3 		– Sell
-41,698
Closed -$1.03M – 2147
2020
Q2 		$1.03M Buy
+41,698
New +$1.13M 0.03% 728
2019
Q3 		– Sell
-12,784
Closed -$102K – 1585
2019
Q2 		$102K Buy
+12,784
New +$128K ﹤0.01% 1019

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

ExodusPoint Capital Management's RCUS Position: Q1 2025 in Review

ExodusPoint Capital Management sold out of Arcus Biosciences (RCUS) in Q1 2025, closing a stake of 60,193 shares — an estimated $896K sold.

ExodusPoint Capital Management first reported a position in RCUS in Q2 2019 and held it in 13 quarters. The position peaked at $8.87M in Q2 2023. 186 funds tracked by Wall St. Rank hold RCUS as of Q1 2025.

  • ExodusPoint Capital Management reported no remaining Arcus Biosciences position as of Q1 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 60,193 Arcus Biosciences shares in Q1 2025, an estimated $896K.
  • ExodusPoint Capital Management first reported a position in Arcus Biosciences in Q2 2019 and held it in 13 quarters.
  • ExodusPoint Capital Management's Arcus Biosciences position peaked at $8.87M in Q2 2023.
  • 186 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2025.

Based on ExodusPoint Capital Management's 13F filing for Q1 2025, filed 14 May 2025.